Publication | Closed Access

Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial

Rheumatoid DisorderRheumatologyAutoimmune DiseaseSjögren’s SyndromeLeflunomide–hydroxychloroquine Combination TherapyImmunologyClinical TrialsRandomised Clinical TrialInflammatory Rheumatic DiseaseMedicinePrimary SjögrenInflammatory Arthritis